, Tracking Stock Market Picks
Enter Symbol:
Aflac Incorporated (AFL) [hlAlert]

up 14.06 %

Aflac Incorporated (AFL) rated Overweight with price target $50 by Barclays Capital

Posted on: Monday,  Oct 3, 2011  1:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Aflac Incorporated (NYSE: AFL) on 10/03/2011. Previously Barclays Capital rated Overweight Aflac Incorporated (NYSE: AFL) on 04/18/2011.,
when the stock price was $51.40. Since then, Aflac Incorporated has gained 14.07% as of 12/11/2015's recent price of $58.63.
If you would have followed the previous Barclays Capital's recommendation on AFL, you would have gained 14.06% of your investment in 1698 days.

Aflac Incorporated is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services and making capital available. Its principal business is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in Japan (Aflac Japan). Aflac?s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, long-term care plans and life insurance products.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/3/2011 1:25 PM Buy
34.57 50.00
as of 12/30/2011
1 Week up  0.41 %
1 Month down  -0.41 %
3 Months up  23.77 %
1 YTD up  34.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/18/2011 1:25 PM Buy
51.40 66.00
1/12/2010 1:44 PM Sell
50.63 52.00
4/22/2009 8:25 AM Sell
27.64 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy